Evidence map›Paper›PMID 34870708›Full record

ArticleClinical science (London, England : 1979)2021

Salt loading decreases urinary excretion and increases intracellular accumulation of uromodulin in stroke-prone spontaneously hypertensive rats.

Sheon Mary, Philipp Boder, Giacomo Rossitto, Lesley Graham, Kayley Scott, Arun Flynn, David Kipgen, Delyth Graham, Christian Delles

Open access · hybridAbstract read
In one paragraph

Article in Clinical science (London, England : 1979), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Insights into Uromodulin and Blood Pressure.Current hypertension reports · 2024
    Review
  6. Uromodulin biology.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  7. Article
  8. Role of Uromodulin in Salt-Sensitive Hypertension.Hypertension (Dallas, Tex. : 1979) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Sheon Mary *Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, U.K.ORCID 0000-0001-9392-3020
Philipp Boder *Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, U.K.
Giacomo RossittoInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, U.K.ORCID 0000-0001-9023-0835
Lesley GrahamInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, U.K.
Kayley ScottInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, U.K.
Arun FlynnInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, U.K.
David KipgenDepartment of Pathology, Queen Elizabeth University Hospital, Glasgow, Scotland, U.K.
Delyth GrahamInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, U.K.
Christian DellesInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland, U.K.ORCID 0000-0003-2238-2612
University of Glasgow · GBQueen Elizabeth University Hospital · GBUniversity of Padua · IT

Funding

British Heart Foundation FS/17/63/33485British Heart Foundation FS/18/58/34179British Heart Foundation FS/19/40/34477British Heart Foundation RE/13/5/30177British Heart Foundation RE/18/6/34217
6 · The paper itself

Abstract

Uromodulin (UMOD) is the most abundant renal protein secreted into urine by the thick ascending limb (TAL) epithelial cells of the loop of Henle. Genetic studies have demonstrated an association between UMOD risk variants and hypertension. We aimed to dissect the role of dietary salt in renal UMOD excretion in normotension and chronic hypertension. Normotensive Wistar-Kyoto rats (WKY) and stroke-prone spontaneously hypertensive rats (SHRSP) (n=8/sex/strain) were maintained on 1% NaCl for 3 weeks. A subset of salt-loaded SHRSP was treated with nifedipine. Salt-loading in SHRSP increased blood pressure (ΔSBP 35 ± 5 mmHg, P<0.0001) and kidney injury markers such as kidney injury marker-1 (KIM-1; fold change, FC 3.4; P=0.003), neutrophil gelatinase-associated lipocalin (NGAL; FC, 2.0; P=0.012) and proteinuria. After salt-loading there was a reduction in urinary UMOD excretion in WKY and SHRSP by 26 and 55% respectively, compared with baseline. Nifedipine treatment reduced blood pressure (BP) in SHRSP, however, did not prevent salt-induced reduction in urinary UMOD excretion. In all experiments, changes in urinary UMOD excretion were dissociated from kidney UMOD protein and mRNA levels. Colocalization and ex-vivo studies showed that salt-loading increased intracellular UMOD retention in both WKY and SHRSP. Our study provides novel insights into the interplay among salt, UMOD, and BP. The role of UMOD as a cardiovascular risk marker deserves mechanistic reappraisal and further investigations based on our findings.

Indexed as

AnimalsBlood PressureCalcium Channel BlockersFemaleKidneyMaleNifedipineRatsRats, Inbred SHRRats, Inbred WKYSodium Chloride, DietaryUromodulinCalcium Channel BlockersNifedipineSodium Chloride, DietaryUmod protein, ratUromodulinblood pressurerenal physiologySaltsalt-sensitive hypertensionTamm Horsfall protein

Identifiers

PMID34870708
PMCPMC8689196
OpenAlexW4200131903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.